NEUGEBOREN EDWARD 4
4 · Acasti Pharma Inc. · Filed Dec 20, 2023
Insider Transaction Report
Form 4
NEUGEBOREN EDWARD
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-12-19+22,500→ 22,500 totalExercise: $2.13Exp: 2033-12-19→ Class A Common Shares (22,500 underlying)
Footnotes (1)
- [F1]Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which 10,000 shares vest in equal monthly installments over a period of 12 months (provided that 3/12 of the options shall be deemed to have vested upon the date of grant), and 12,500 shares vest in equal quarterly installments over a period of 18 months (Provided that 1/6 of the options shall be deemed to have vested upon the date of grant).